AMKR vs IMOS: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
AMKR is the larger of the two ($7.55B market cap): the incumbent the market prices for continued execution (10.97x forward earnings, beta 2.40). IMOS is the smaller challenger ($1.26B), actually pricier on forward earnings (35.89x): more room to run, but more to prove. If you believe IMOS earns its premium (35.89x forward earnings, so the market expects more from it), IMOS fits. If you believe in paying less for profit, AMKR fits at 10.97x.
AMKR vs IMOS: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AMKR | IMOS | What it tells you |
|---|---|---|---|
| Market cap | $7.55B | $1.26B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 10.97 | 35.89 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 12.28 | 12.25 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 2.40 | 1.47 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 1% of range | 19% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 1.57 | 1.57 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: AMKR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AMKR and IMOS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMKR and IMOS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMKR and IMOS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Amkor Technology (AMKR) do?
Amkor Technology is one of the world's largest outsourced semiconductor assembly and test (OSAT) providers. After chips are fabricated at TSMC, Samsung, Intel, or other foundries, they need to be packaged (mounted in protective enclosures, connected to external pins) and tested before being sold. Amkor performs this packaging and testing for major customers including Apple, NVIDIA, Qualcomm, AMD, and others.
What does ChipMOS Technologies (IMOS) do?
ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers, integrated device manufacturers, and foundries. Its specialties include memory packaging and testing plus a leading position in chip-on-film (COF) packaging for display driver integrated circuits (DDICs) used in smartphone and TV panels, alongside services like wafer bumping, ball grid array (BGA), and wafer-level chip-scale packaging. The company runs facilities in Taiwan's Hsinchu and Southern Taiwan science parks and is listed both in Taipei (8150) and on Nasdaq as an ADR (IMOS).
AMKR vs IMOS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- AMKR drivers: Advanced packaging for AI accelerators; US fab investment and onshore packaging.
- IMOS drivers: AI-driven memory demand; Chip-on-film and display-driver niche.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: OSAT margins are structurally lower than fabless designers or pure foundries (trailing gross margin is about 16.6%). For IMOS, chipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power.
AMKR or IMOS: which should you pick?
If the story you believe is AMKR's (Advanced packaging for AI accelerators), AMKR is the more direct way to own it; if it is IMOS's (AI-driven memory demand), IMOS is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMKR and IMOS guides.
AMKR vs IMOS: the full fundamentals
AMKR. As of November 20, 2026, Amkor trades at about 12x trailing and 11x forward earnings, with a price-to-sales ratio near 1.0x and EV/EBITDA around 6x, far cheaper than earlier in 2026 because earnings rose while the share price fell by more than two-thirds from its high. Consensus for the December quarter is EPS of about $0.72 on about $1.96 billion of revenue, and about $2.78 of EPS on $8.6 billion of revenue for 2027. The 10 analysts in the digest rate it a Buy on average, with a mean target near $66, more than double the current price.
IMOS. The trailing P/E has fallen from near 98 in July 2026 and about 30 in October to about 12, because third quarter profit kept rising while the ADR dropped about 35% in a month. Consensus revenue estimates of about NT$31.3 billion for 2026 and NT$35.3 billion for 2027 assume the memory upcycle carries on; financial figures are in New Taiwan dollars while the ADR price and market value are in US dollars.
Headline figures (approximate, November 2026): AMKR shows revenue (ttm) ~$7.5 billion, revenue growth (q3 2026, yoy) ~0.2% (computing +37%, communications -28%), gross margin (q3 2026) ~18.3% (thin, typical for OSAT), net income (ttm) ~$619 million (EPS ~$2.48); IMOS shows revenue (ttm to september 2026) ~NT$29.2B, up ~37% year over year in the latest quarter, q3 2026 revenue ~NT$8.4B, a record, up ~37% year over year; October 2026 ~NT$2.85B, up ~31%, net income (ttm) ~NT$3.22B; Q3 2026 net income ~NT$1.32B, margins (ttm) Gross ~17%, operating ~13%, net ~11%.
The bottom line: AMKR vs IMOS
AMKR and IMOS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined AMKR and IMOS exposure against your real portfolio. It is not an investment adviser.
Wondering how AMKR or IMOS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Amkor Technology
Ask Walnut's AI anything about AMKR and see how it fits what you own.
FAQ
What is the difference between AMKR and IMOS?
+
Amkor Technology is one of the world's largest outsourced semiconductor assembly and test (OSAT) providers. ChipMOS Technologies provides back-end semiconductor services: it assembles and tests chips for fabless designers, integrated device manufacturers, and foundries. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AMKR or IMOS the better stock?
+
Neither is universally better. AMKR is the larger incumbent; IMOS is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AMKR or IMOS?
+
On forward P/E (as of November 2026), AMKR trades at 10.97x and IMOS at 35.89x, so AMKR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AMKR and IMOS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AMKR vs IMOS?
+
AMKR: OSAT margins are structurally lower than fabless designers or pure foundries (trailing gross margin is about 16.6%). Capex requirements for advanced packaging are substantial, and in 2026 they have outrun operating cash flow of about $1.51 billion, leaving trailing free cash flow near -$591 million and total debt of about $2.71 billion against about $2.38 billion of cash. Customer concentration with the largest fabless designers and smartphone makers is meaningful: communications revenue fell 28% in Q3 2026 to 37% of the total, and management expects another high-single-digit sequential decline in that segment in Q4. The stock is highly volatile: it fell about 38% in three months and 23% in the past month to November 20, 2026, ending near its 52-week low of about $30. Analysts expect EPS growth to slow from about 67% in 2026 to about 11% in 2027, so the AI packaging story has to keep delivering. IMOS: ChipMOS is a small OSAT competing against giants like ASE and Amkor and specialist peers like Powertech, so it lacks their scale, diversification, and pricing power. Its revenue is concentrated in two volatile end-markets, memory and consumer display drivers, meaning a downturn in smartphone sales or memory prices hits results directly and severely. Net profit already fell sharply in 2025 on higher non-operating expenses and lower operating profit, and gross margins are thin (about 17% on a trailing basis), so earnings are highly cyclical. As a Taiwan-based ADR, the stock also carries currency, geopolitical, and cross-listing risks. Trailing free cash flow was negative (roughly NT$-1.3 billion) as capacity spending rose, and the ADR has already shown how fast sentiment can turn: it fell about 35% in the month to 20 November 2026, from a 52-week high near $84 earlier in the year, even as monthly revenue kept growing about 30% year over year. Analyst coverage of the ADR is thin, with no consensus price target on Yahoo Finance.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMKR or IMOS; figures are approximate and dated (as of November 2026). Verify current data before investing.